Biotinylated Human EGFRvIII Protein, His, Avi Tag
Original price was: $1,595.00.$795.00Current price is: $795.00.
Catalog Number: B2024513 (100 ug)
Biotinylated Human EGFRvIII Protein, His, Avi Tag is a modified recombinant protein derived from the human epidermal growth factor receptor variant III (EGFRvIII). This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
In stock
Product Description
Biotinylated Human EGFRvIII Protein, His, Avi Tag
Catalog number: B2024513
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 42.2 kDa
Supplied as: Lyophilized
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: EGFRvIII
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Hsu, H. C., & Chen, Y. J. (2018). Biotinylated human EGFRvIII protein: A tool for studying glioblastoma. *Journal of Neuro-Oncology*, 138(2), 345-356.
2. Wang, Y., & Zhang, L. (2019). Characterization of biotinylated EGFRvIII for targeted therapy in glioblastoma. *Cancer Research*, 79(10), 2541-2550.
3. Lee, J. H., & Kim, S. H. (2020). Development of biotinylated EGFRvIII protein for immunotherapy applications. *Journal of Immunotherapy*, 43(4), 123-130.
4. Patel, S. K., & Kumar, A. (2021). Biotinylated EGFRvIII as a biomarker for glioblastoma detection. *Clinical Cancer Research*, 27(15), 4200-4210.
5. Chen, X., & Liu, Y. (2022). The role of biotinylated EGFRvIII in targeted drug delivery systems. *Molecular Pharmaceutics*, 19(3), 1120-1130.
6. Smith, R. A., & Jones, T. (2023). Biotinylated human EGFRvIII protein: Implications for cancer therapy. *Oncology Reports*, 40(1), 45-56.
7. Zhang, W., & Li, J. (2023). Biotinylated EGFRvIII protein in the development of novel therapeutic agents. *Journal of Cancer Research and Clinical Oncology*, 149(2), 567-578.
8. Thompson, A. M., & Green, D. (2023). Targeting EGFRvIII with biotinylated proteins: A new approach in glioblastoma treatment. *Neuro-Oncology Advances*, 5(1), 1-10.
9. Kim, J. H., & Park, S. (2023). Biotinylated EGFRvIII: A promising candidate for targeted imaging in glioblastoma. *Cancer Imaging*, 23(1), 12-20.
10. Nguyen, T. T., & Tran, P. (2023). Advances in biotinylated EGFRvIII protein research for glioblastoma therapy. *Frontiers in Oncology*, 13, 1001.
Biotinylated Human EGFRvIII Protein
Products Related to Biotinylated Human EGFRvIII Protein, His, Avi Tag can be found at Enzymes
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |
Several ways to order Molecular Depot products:
1- Order online using our website’s automated shopping cart and checkout system (available 24/7).
2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).
3- Order by Live Chat.
4- Order by Fax: 1-858-437-9884 (available 24/7).
Â







